Vijay Kumar Prajapati
Vijay Kumar Prajapati
Assistant Professor, Central University of Rajasthan
Verified email at - Homepage
TitleCited byYear
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ...
Clinical infectious diseases 55 (4), 543-550, 2012
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes
VK Prajapati, K Awasthi, S Gautam, TP Yadav, M Rai, ON Srivastava, ...
Journal of antimicrobial chemotherapy 66 (4), 874-879, 2011
Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis
V Bhandari, A Kulshrestha, DK Deep, O Stark, VK Prajapati, V Ramesh, ...
PLoS neglected tropical diseases 6 (5), e1657, 2012
Antileishmanial activity of nano-amphotericin B deoxycholate
KD Manandhar, TP Yadav, VK Prajapati, S Kumar, M Rai, A Dube, ...
Journal of Antimicrobial Chemotherapy 62 (2), 376-380, 2008
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells
R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ...
International journal for parasitology 41 (13-14), 1311-1321, 2011
An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis
VK Prajapati, K Awasthi, TP Yadav, M Rai, ON Srivastava, S Sundar
Journal of Infectious Diseases 205 (2), 333-336, 2011
Circulating microRNAs: potential and emerging biomarkers for diagnosis of human infectious diseases
P Verma, RK Pandey, P Prajapati, VK Prajapati
Frontiers in microbiology 7, 1274, 2016
Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India
P Srivastava, VK Prajapati, M Vanaerschot, G Van der Auwera, ...
Infection, Genetics and Evolution 10 (7), 1145-1150, 2010
Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic
P Srivastava, VK Prajapati, M Rai, S Sundar
Journal of clinical microbiology 49 (8), 3088-3091, 2011
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
MR Perry, S Wyllie, VK Prajapati, J Feldmann, S Sundar, M Boelaert, ...
PLoS neglected tropical diseases 5 (9), e1227, 2011
Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis
R Maurya, S Mehrotra, VK Prajapati, S NylÚn, D Sacks, S Sundar
Journal of clinical microbiology 48 (5), 1932-1934, 2010
Molecular docking and in vitro antileishmanial evaluation of chromene-2-thione analogues
RK Verma, VK Prajapati, GK Verma, D Chakraborty, S Sundar, M Rai, ...
ACS medicinal chemistry letters 3 (3), 243-247, 2012
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection
M Ali, RK Pandey, N Khatoon, A Narula, A Mishra, VK Prajapati
Scientific reports 7 (1), 9232, 2017
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
N Khatoon, RK Pandey, VK Prajapati
Scientific reports 7 (1), 8285, 2017
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules
S Sundar, V Kumar Prajapati
Current medicinal chemistry 19 (19), 3196-3202, 2012
In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis
VK Prajapati, S Sharma, M Rai, B Ostyn, P Salotra, M Vanaerschot, ...
The American journal of tropical medicine and hygiene 89 (4), 750-754, 2013
Brief Definitive Report: Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen
R Maurya, R Kumar, VK Prajapati, KD Manandhar, D Sacks, S Sundar, ...
Parasite immunology 32 (7), 479-483, 2010
Perturbed microRNA expression by Mycobacterium tuberculosis promotes macrophage polarization leading to pro-survival foam cell
PK Ahluwalia, RK Pandey, PK Sehajpal, VK Prajapati
Frontiers in immunology 8, 107, 2017
Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study
MR Perry, VK Prajapati, J Menten, A Raab, J Feldmann, D Chakraborti, ...
PLoS neglected tropical diseases 9 (3), e0003518, 2015
The system can't perform the operation now. Try again later.
Articles 1–20